| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 04/14/2004 | EP1406656A2 METHODS OF ADMINISTERING ANTI-TNF$g(a) ANTIBODIES |
| 04/14/2004 | EP1406654A2 Methods for regulating bacteria |
| 04/14/2004 | EP1406653A2 T cell regulatory genes and methods of use thereof |
| 04/14/2004 | EP1406650A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |
| 04/14/2004 | EP1406644A2 Modified proteins, designer toxins, and methods of making thereof |
| 04/14/2004 | EP1406642A2 Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections |
| 04/14/2004 | EP1406626A2 Sulphonyl aryl hydroxamates and their use as mmp inhibitors |
| 04/14/2004 | EP1406618A2 Use of nk-1 receptor antagonists with pyridinic structure for the treatment of brain, spinal or nerve injury |
| 04/14/2004 | EP1406611A2 Method for treating fibrotic diseases or other indications |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1406608A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1406597A1 Controlled drug delivery systems providing variable release rates |
| 04/14/2004 | EP1189583A4 Indole derivatives |
| 04/14/2004 | EP1140072B1 Compounds and methods |
| 04/14/2004 | EP1040097B1 Potassium channel openers |
| 04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
| 04/14/2004 | EP0839041B1 Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts |
| 04/14/2004 | EP0765392B1 Interleukin-5 specific recombinant antibodies |
| 04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
| 04/14/2004 | CN1489586A Indazolyl-substituted pyrroline compounds as kinase inhibitor |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
| 04/14/2004 | CN1489469A Medicine for lung cnncer |
| 04/14/2004 | CN1489467A Pharmacentical formulation comprising pyrazolo[4,3-d] pyrimdine and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/14/2004 | CN1488646A SARS virus S protein and N protein fusion protein, and preparation and use thereof |
| 04/14/2004 | CN1488645A Specific antibody IgY for anti SARS virus, and preparing method thereof and composition containing same and its use |
| 04/14/2004 | CN1488641A Polypeptide medicine for inhibiting SARS coronavirus, and derivatives and use thereof |
| 04/14/2004 | CN1488634A Rare earth heteropolyacid salt anti SARS virus medicine and synthesizing method thereof |
| 04/14/2004 | CN1488402A Novel medicinal use of proteinase inhibior for preventing and curing lang disease |
| 04/14/2004 | CN1488401A Use of preparing medicine for treating respiratory and cyclic failure |
| 04/14/2004 | CN1488380A Use of chinese medicine composition in preparing medicine for anti SARS virus |
| 04/14/2004 | CN1488378A SARS epidemic-removing pill |
| 04/14/2004 | CN1488368A Medicine for treating nasitis |
| 04/14/2004 | CN1488355A Cough-relieving chinese medicine formulation of total glycoside of mango leaf |
| 04/14/2004 | CN1488350A Eye preparation for mulating prescription suitable for ciprofloxacin and use method thereof |
| 04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
| 04/14/2004 | CN1145608C Quanternary ammonium compounds as anti-tussive agents |
| 04/14/2004 | CN1145494C Medicine for treating nasosinusitis and its preparation method |
| 04/14/2004 | CN1145489C Inositol polyphosphate derivatives and mthod of using same |
| 04/14/2004 | CN1145485C 8-chloro-6,11-dihydro-11-(4-piperidy lidene)-5H-benzo[5,6] cyclohepta [1,2,-b] pyridine oral compositions |
| 04/14/2004 | CN1145478C Pharmaceutical aerosol formulation |
| 04/13/2004 | US6720452 Adamantane derivatives |
| 04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
| 04/13/2004 | US6720336 4,4-biarylpiperidine derivatives |
| 04/13/2004 | US6720328 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) |
| 04/13/2004 | US6720325 CCR5 antagonists useful for treating aids |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/13/2004 | CA2311122C Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood |
| 04/08/2004 | WO2004029192A2 Producing method of tien hsien liquid |
| 04/08/2004 | WO2004029054A1 Novel adenine compound and use thereof |
| 04/08/2004 | WO2004029041A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/08/2004 | WO2004028545A1 A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
| 04/08/2004 | WO2004028518A1 Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set |
| 04/08/2004 | WO2004015091A3 Preparation of type ii pneumocytes from stem cells |
| 04/08/2004 | WO2004013153A3 Macrolide compounds endowed with antiinflammatory activity |
| 04/08/2004 | WO2004011444A3 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 04/08/2004 | WO2003105775A3 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 04/08/2004 | WO2003097622A3 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003084503A3 P38 kinase inhibitors for treating mucus hypersecretion_ |
| 04/08/2004 | WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040068020 Patient oxygenation using stabilized fluorocarbon emulsions |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067945 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067491 Diagnosis of diseases associated with metabolism |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067261 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 04/08/2004 | US20040067237 Using a rational selection of representative PspAs from various families of clades to produce broadly efficacious Pneumococcal vaccines |
| 04/08/2004 | US20040067202 Novel alkanoic acid derivaties |
| 04/08/2004 | CA2497765A1 8-hydroxy substituted adenine compounds and uses thereof |
| 04/08/2004 | CA2497280A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 04/07/2004 | EP1405844A1 Cycloalkenone derivative |
| 04/07/2004 | EP1405645A1 Remedies for eosinophilic diseases |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404873A2 Chimeric immunomodulatory compounds and methods of using the same |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404676A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404669A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |